Camber Capital Management as of Dec. 31, 2018
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 34 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 12.7 | $267M | 2.0M | 133.66 | |
| Tesaro | 9.9 | $208M | 2.8M | 74.25 | |
| Mylan Nv | 7.8 | $164M | 6.0M | 27.40 | |
| Universal Health Services (UHS) | 5.0 | $105M | 900k | 116.56 | |
| McKesson Corporation (MCK) | 4.6 | $97M | 875k | 110.47 | |
| Celgene Corporation | 4.6 | $96M | 1.5M | 64.09 | |
| Global Blood Therapeutics In | 4.4 | $92M | 2.3M | 41.05 | |
| Perrigo Company (PRGO) | 4.0 | $85M | 2.2M | 38.75 | |
| GlaxoSmithKline | 3.6 | $76M | 2.0M | 38.21 | |
| Biogen Idec (BIIB) | 3.6 | $75M | 250k | 300.92 | |
| Atara Biotherapeutics (ATRA) | 3.1 | $66M | 1.9M | 34.74 | |
| Nektar Therapeutics (NKTR) | 3.1 | $66M | 2.0M | 32.87 | |
| Alexion Pharmaceuticals | 2.8 | $58M | 600k | 97.36 | |
| Tenet Healthcare Corporation (THC) | 2.6 | $56M | 3.3M | 17.14 | |
| Bristol Myers Squibb (BMY) | 2.5 | $52M | 1.0M | 51.98 | |
| Clovis Oncology | 2.4 | $50M | 2.8M | 17.96 | |
| Brookdale Senior Living (BKD) | 2.4 | $50M | 7.5M | 6.70 | |
| Cardinal Health (CAH) | 2.1 | $45M | 1.0M | 44.60 | |
| Momenta Pharmaceuticals | 2.1 | $44M | 4.0M | 11.04 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $44M | 600k | 72.91 | |
| AMAG Pharmaceuticals | 1.9 | $40M | 2.7M | 15.19 | |
| Medicines Company | 1.8 | $38M | 2.0M | 19.14 | |
| Sarepta Therapeutics (SRPT) | 1.8 | $38M | 350k | 109.13 | |
| Synthorx | 1.5 | $32M | 1.9M | 17.38 | |
| Zymeworks | 1.5 | $32M | 2.2M | 14.68 | |
| Hca Holdings (HCA) | 1.5 | $31M | 250k | 124.45 | |
| Puma Biotechnology (PBYI) | 1.3 | $27M | 1.3M | 20.35 | |
| Arena Pharmaceuticals | 0.9 | $20M | 500k | 38.95 | |
| Bausch Health Companies (BHC) | 0.9 | $19M | 1.0M | 18.47 | |
| Eagle Pharmaceuticals (EGRX) | 0.6 | $12M | 292k | 40.29 | |
| DaVita (DVA) | 0.4 | $8.6M | 168k | 51.46 | |
| Endologix | 0.3 | $6.7M | 9.3M | 0.72 | |
| Sutro Biopharma (STRO) | 0.3 | $5.4M | 600k | 9.02 | |
| Surgery Partners (SGRY) | 0.1 | $1.6M | 160k | 9.79 |
